Uromigos-ASCO 2023-Prostate Cancer

Advertisement
The UromigosThe Uromigos | August 1, 2023
Karim Fizazi, MD, PhD, discusses the radiotherapy components of the PEACE-1 study on abiraterone and prednisone added to ADT.
Listen Now
The UromigosThe Uromigos | August 1, 2023
Karim Fizazi joins us at ASCO 2023 to discuss results from the TALAPRO-2 study on talazoparib plus enzalutamide for mCRPC.
Advertisement
Advertisement
Advertisement